Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Aide

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Plos Neglected Tropical Diseases|May 2, 2020
Escherichia coli ST131 clones harbouring AggR and AAF/V fimbriae causing bacteremia in Mozambican children: Emergence of new variant of fimH27 subcloneInácio Mandomando, Delfino Vubil, Nadia Boisen, et al.
NPJ Vaccines|August 8, 2022
Author Correction: Antibody responses to the RTS,S/AS01<sub>E</sub> vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in MozambiqueLina Sánchez, Marta Vidal, Chenjerai Jairoce, et al.
Malaria Journal|July 14, 2025
Efficacy of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Mozambique, 2022Abel Nhama, Arlindo Chidimatembue, Lídia Nhamussua, et al.
Immunobiology|January 25, 2011
IgG against Plasmodium falciparum variant surface antigens and growth inhibitory antibodies in Mozambican children receiving intermittent preventive treatment with sulfadoxine-pyrimethamineDiana Quelhas, Alfons Jiménez, Llorenç Quintó, et al.
Plos Medicine|August 16, 2020
A multiphase program for malaria elimination in southern Mozambique (the Magude project): A before-after studyBeatriz Galatas, Francisco Saúte, Helena Martí-Soler, et al.
Journal of Global Health|February 21, 2025
Paediatric healthcare in Manhiça district through a gender lens: a retrospective analysis of 17 years of morbidity and demographic surveillance dataNúria Balanza, Aura Hunguana, Sara Ajanovic, et al.
Clinical and Vaccine Immunology : CVI|December 16, 2011
Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican childrenCarlota Dobaño, Diana Quelhas, Llorenç Quintó, et al.
Lancet (London, England)|December 13, 2005
Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trialPedro L Alonso, Jahit Sacarlal, John J Aponte, et al.
BMC Public Health|July 3, 2026
Implementation, coverage and impact of a programmatic mass drug administration campaign for malaria in southern MozambiqueMaria Tusell, Laura Fuente-Soro, Arsénio Nhacolo, et al.
The Journal of Infectious Diseases|July 3, 2009
Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican childrenJahit Sacarlal, Pedro Aide, John J Aponte, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Plos Neglected Tropical Diseases|May 2, 2020
Escherichia coli ST131 clones harbouring AggR and AAF/V fimbriae causing bacteremia in Mozambican children: Emergence of new variant of fimH27 subcloneInácio Mandomando, Delfino Vubil, Nadia Boisen, et al.
NPJ Vaccines|August 8, 2022
Author Correction: Antibody responses to the RTS,S/AS01<sub>E</sub> vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in MozambiqueLina Sánchez, Marta Vidal, Chenjerai Jairoce, et al.
Malaria Journal|July 14, 2025
Efficacy of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Mozambique, 2022Abel Nhama, Arlindo Chidimatembue, Lídia Nhamussua, et al.
Immunobiology|January 25, 2011
IgG against Plasmodium falciparum variant surface antigens and growth inhibitory antibodies in Mozambican children receiving intermittent preventive treatment with sulfadoxine-pyrimethamineDiana Quelhas, Alfons Jiménez, Llorenç Quintó, et al.
Plos Medicine|August 16, 2020
A multiphase program for malaria elimination in southern Mozambique (the Magude project): A before-after studyBeatriz Galatas, Francisco Saúte, Helena Martí-Soler, et al.
Journal of Global Health|February 21, 2025
Paediatric healthcare in Manhiça district through a gender lens: a retrospective analysis of 17 years of morbidity and demographic surveillance dataNúria Balanza, Aura Hunguana, Sara Ajanovic, et al.
Clinical and Vaccine Immunology : CVI|December 16, 2011
Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican childrenCarlota Dobaño, Diana Quelhas, Llorenç Quintó, et al.
Lancet (London, England)|December 13, 2005
Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trialPedro L Alonso, Jahit Sacarlal, John J Aponte, et al.
BMC Public Health|July 3, 2026
Implementation, coverage and impact of a programmatic mass drug administration campaign for malaria in southern MozambiqueMaria Tusell, Laura Fuente-Soro, Arsénio Nhacolo, et al.
The Journal of Infectious Diseases|July 3, 2009
Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican childrenJahit Sacarlal, Pedro Aide, John J Aponte, et al.
Pageof 11